Efficacy and safety of tamsulosin 0.4 mg single pills for treatment of Asian patients with symptomatic benign prostatic hyperplasia with lower urinary tract symptoms: a randomized, double-blind, phase 3 trial-Reference-Cited by-同舟云学术

Efficacy and safety of tamsulosin 0.4 mg single pills for treatment of Asian patients with symptomatic benign prostatic hyperplasia with lower urinary tract symptoms: a randomized, double-blind, phase 3 trial

Published:2018-04-12 Issue:10 Volume:34 Page:1793-1801
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Chung Jae Hoon¹,Oh Cheol Young²,Kim Jae Heon³,Ha U-Syn⁴,Kim Tae Hyo⁵,Lee Seung Hwan⁶,Han Jun Hyun²,Bae Jae Hyun⁷,Chang In Ho⁸,Han Deok Hyun⁹,Yoo Tag Keun¹⁰,Chung Jae Il¹¹,Kim Sae Woong¹²,Jung Jina¹³,Kim Yong-Il¹³,Lee Seung Wook¹

Affiliation:

1. Department of Urology, Hanyang University College of Medicine, Seoul, Korea;

2. Department of Urology, Hallym University College of Medicine, Seoul, Korea;

3. Department of Urology, Soonchunhyang University College of Medicine, Seoul, Korea;

4. Department of Urology, College of Medicine, The Catholic University of Korea, Yeoido St Mary’s Hospital, Seoul, Korea;

5. Department of Urology, Dong-A University College of Medicine, Busan, Korea;

6. Department of Urology, Yonsei University College of Medicine, Seoul, Korea;

7. Department of Urology, Korea University College of Medicine, Seoul, Korea;

8. Department of Urology, Chung-Ang University College of Medicine, Seoul, Korea;

9. Department of Urology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea;

10. Department of Urology, Eulji University College of Medicine, Seoul, Korea;

11. Department of Urology, Inje University College of Medicine, Seoul, Korea;

12. Department of Urology, College of Medicine, The Catholic University of Korea, Seoul St Mary’s Hospital, Seoul, Korea;

13. Hanmi Pharmaceutical Co. Ltd., Seoul, Korea

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1447451

Reference17 articles.

1. Epidemiology of Benign Prostatic Hyperplasia and Comorbidities in Racial and Ethnic Minority Populations

2. Finasteride

3. Evaluation of patient outcome after discontinuation of alfuzosin treatment for benign prostatic hyperplasia: a multicentre, prospective study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: a systematic review and network meta-analysis;Scientific Reports;2024-05-15

2. Cervi Parvum Cornu complex for men with lower urinary tract symptoms: a multicenter, randomized, double-blind, placebo-controlled trial;Prostate International;2023-12

3. Safety and efficacy of tamsulosin 0.4 mg as an initial dose in 1,219 Korean patients with moderate to severe lower urinary tract symptoms: data from a phase IV study;Prostate International;2023-12

4. Quisqualis indica extract for men with lower urinary tract symptoms: A randomized, double-blind, placebo-controlled trial;Investigative and Clinical Urology;2023

5. Effect of alpha-adrenoceptor antagonists on sexual function. A systematic review and meta-analysis;Archivio Italiano di Urologia e Andrologia;2022-06-30